RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth.
about
Pathways to Specialized Ribosomes: The Brussels LectureWhole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicityBattle against cancer: an everlasting saga of p53.Global proteomic analysis of lysine acetylation in zebrafish (Danio rerio) embryos.How Ribosomes Translate Cancer.Ribosomal protein S27-like regulates autophagy via the β-TrCP-DEPTOR-mTORC1 axis
P2860
RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
RPL24: a potential therapeutic ...... sembly and cancer cell growth.
@en
type
label
RPL24: a potential therapeutic ...... sembly and cancer cell growth.
@en
prefLabel
RPL24: a potential therapeutic ...... sembly and cancer cell growth.
@en
P2093
P2860
P356
P1433
P1476
RPL24: a potential therapeutic ...... sembly and cancer cell growth.
@en
P2093
Amanuel Kehasse
Bianca S Gabriel
Birgit Schilling
Bradford W Gibson
Christina Yau
Christopher C Benz
Daniel E Rothschild
Gary K Scott
Ingrid M Hanson
Jason M Held
P2860
P304
P356
10.18632/ONCOTARGET.2099
P407
P577
2014-07-01T00:00:00Z